Morgan Stanley Akoya Biosciences, Inc. Transaction History

Morgan Stanley

$1.49 Trillion
Q2 2025

A detailed history of Morgan Stanley transactions in Akoya Biosciences, Inc. stock. As of the latest transaction made, Morgan Stanley holds 83,019 shares of AKYA stock, worth $107,094. This represents 0.0% of its overall portfolio holdings.

Number of Shares

83,019

Previous 113,698 26.98%

Holding current value

$107,094

Previous $158,000 32.28%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 15, 2025	SELL	$0.95 - $1.36 $29,145 - $41,723	-30,679 Reduced 26.98%	83,019 $107,000
Q1 2025 May 15, 2025	SELL	$1.39 - $3.23 $22,338 - $51,909	-16,071 Reduced 12.38%	113,698 $158,000
Q4 2024 Feb 14, 2025	SELL	$2.07 - $3.24 $84,128 - $131,680	-40,642 Reduced 23.85%	129,769 $297,000
Q3 2024 May 14, 2025	BUY	$1.96 - $2.94 $121,964 - $182,947	62,227 Added 57.52%	170,411 $463,000
Q3 2024 Nov 14, 2024	BUY	$1.96 - $2.94 $121,964 - $182,947	62,227 Added 57.52%	170,411 $463,000
Q2 2024 May 14, 2025	SELL	$1.94 - $4.56 $41,874 - $98,427	-21,585 Reduced 16.63%	108,184 $253,000
Q2 2024 Oct 17, 2024	BUY	$1.94 - $4.56 $86,170 - $202,546	44,418 Added 69.66%	108,184 $253,000
Q2 2024 Aug 14, 2024	BUY	$1.94 - $4.56 $86,170 - $202,546	44,418 Added 69.66%	108,184 $253,000
Q1 2024 Oct 17, 2024	SELL	$4.33 - $6.06 $192,329 - $269,173	-44,418 Reduced 41.06%	63,766 $299,000
Q1 2024 Aug 16, 2024	SELL	$4.33 - $6.06 $99,732 - $139,579	-23,033 Reduced 26.54%	63,766 $299,000
Q1 2024 May 15, 2024	SELL	$4.33 - $6.06 $99,732 - $139,579	-23,033 Reduced 26.54%	63,766 $299,000
Q4 2023 Aug 16, 2024	SELL	$3.13 - $5.13 $66,935 - $109,705	-21,385 Reduced 19.77%	86,799 $423,000
Q4 2023 Feb 13, 2024	BUY	$3.13 - $5.13 $166,813 - $273,403	53,295 Added 159.07%	86,799 $423,000
Q3 2023 Nov 15, 2023	SELL	$4.24 - $7.44 $15,755 - $27,647	-3,716 Reduced 9.98%	33,504 $155,000
Q2 2023 Aug 14, 2023	BUY	$5.28 - $8.35 $38,913 - $61,539	7,370 Added 24.69%	37,220 $275,000
Q1 2023 May 15, 2023	SELL	$7.6 - $12.68 $101,460 - $169,278	-13,350 Reduced 30.9%	29,850 $244,000
Q4 2022 Feb 14, 2023	SELL	$8.6 - $14.1 $17,741 - $29,088	-2,063 Reduced 4.56%	43,200 $413,000
Q3 2022 Nov 14, 2022	SELL	$10.63 - $15.76 $57,752 - $85,624	-5,433 Reduced 10.72%	45,263 $532,000
Q2 2022 Oct 27, 2022	BUY	$8.38 - $12.85 $86,942 - $133,318	10,375 Added 25.73%	50,696 $651,000
Q2 2022 Aug 15, 2022	BUY	$8.38 - $12.85 $86,942 - $133,318	10,375 Added 25.73%	50,696 $651,000
Q1 2022 Oct 27, 2022	SELL	$9.84 - $14.97 $102,090 - $155,313	-10,375 Reduced 20.47%	40,321 $444,000
Q1 2022 May 13, 2022	BUY	$9.84 - $14.97 $115,974 - $176,436	11,786 Added 41.3%	40,321 $444,000
Q4 2021 Feb 14, 2022	SELL	$11.37 - $15.31 $1.08 Million - $1.45 Million	-94,616 Reduced 76.83%	28,535 $436,000
Q3 2021 Nov 15, 2021	BUY	$13.04 - $21.0 $1.61 Million - $2.59 Million	123,151 New	123,151 $1.72 Million

Others Institutions Holding AKYA

# of Institutions

Shares Held

13.8M

Call Options Held

Put Options Held

14K

View Full List

About Akoya Biosciences, Inc.

Ticker AKYA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 37,892,300
Market Cap $48.9M
Description
Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope...

More about AKYA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account